The proton-coupled folate transporter (PCFT/SLC46A1) displays optimal and Prominent folate and antifolate transport activity at acidic pH in human carcinoma cells but poor activity ill leukemia cells. Consistently herein, human leukemia cell lines expressed Poor PCFT transcript levels, whereas various carcinoma cell lines showed substantial PUT gene expression. We identified a CpG island with high density at nucleotides -200 through +100 and explored its role in PCFT promoter silencing. Leukemia cells with barely detectable PCFT transcripts consistently harbored 85-100% methylation of this CpG island, whereas no methylation was found in carcinoma cells. Treatment with 5-Aza-2'-deoxycytidine which induced demethylation but not with the histone deacetylase inhibitor trichostatin A, restored 50-fold PUT expression only in leukemia cells. These findings constitute the first demonstration of the dominant epigenetic silencing of the PCFT gene in leukemia cells. The potential translational implications of the restoration of PCFT expression in chemotherapy of leukemia are discussed. (C) 2008 Elsevier Inc. All rights reserved.